Source: WRAL TechWire

Entegrion: RTP-based Entegrion infuses $4.2M debt funding

Entegrion, a Research Triangle=based life sciences company developing advanced blood products, has raised $4.2 million of a $5 million debt and securities offering from 59 investors, according to a regulatory filing.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
CEO Avatar

President & CEO

Bert Valada

CEO Approval Rating

82/100

Read more